Delphard Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 12.70%
(FY 2023)
- Profit 252.22%
(FY 2023)
- Ebitda 169.41%
(FY 2023)
- Net Worth 18.13%
(FY 2023)
- Total Assets 2.15%
(FY 2023)
About Delphard Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bharatkumar Patel, Pintu Kumar, Pareshkumar Dhameliya, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24303GJ2018PTC104923
- Company No.
104923
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Oct 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Delphard Healthcare?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjaykumar Thumar  | Director | 22-Jan-2019 | Current |
| Ashwin Desai | Director | 22-Jan-2019 | Current |
| Bharatkumar Patel | Director | 24-Sep-2019 | Current |
| Pintu Kumar | Director | 25-Oct-2018 | Current |
| Pareshkumar Dhameliya | Director | 25-Oct-2018 | Current |
| Rakesh Khoont | Director | 22-Jan-2019 | Current |
Financial Performance of Delphard Healthcare.
Delphard Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.7% increase. The company also saw a substantial improvement in profitability, with a 252.22% increase in profit. The company's net worth Soared by an impressive increase of 18.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Delphard Healthcare?
In 2023, Delphard Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Lupitas Pharmaceuticals Private LimitedActive 10 years 8 monthsPareshkumar Dhameliya is a mutual person
- Scutonix Lifesciences Private LimitedActive 6 years 1 month
Rakesh Khoont, Sanjaykumar Thumar and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Delphard Healthcare?
Unlock and access historical data on people associated with Delphard Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Delphard Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Delphard Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
